UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Single-Cell RNA Sequencing of the Cardiovascular System: New Looks for Old Diseases

Frontiers in cardiovascular medicine, 2019-12, Vol.6, p.173

2019

Volltextzugriff (PDF)

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

Nature medicine, 2022-04, Vol.28 (4), p.809-813

2022

Volltextzugriff (PDF)

Relation of Worsened Renal Function During Hospitalization for Heart Failure to Long-Term Outcomes and Rehospitalization

The American journal of cardiology, 2011, Vol.107 (1), p.74-78

2011

Volltextzugriff (PDF)

Ventricular Assist Devices: Is Destination Therapy a Viable Alternative in the Non-Transplant Candidate?

Current heart failure reports, 2013-03, Vol.10 (1), p.101-107

2013

Volltextzugriff (PDF)

Adrenergic-Pathway Gene Variants Influence Beta-Blocker–Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner

Journal of the American College of Cardiology, 2012-09, Vol.60 (10), p.898-907

2012

Volltextzugriff (PDF)

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction

Cardiology and therapy, 2020-12, Vol.9 (2), p.561-568

2020

Volltextzugriff (PDF)

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide

Cardiovascular drugs and therapy, 2018-08, Vol.32 (4), p.319-328

2018

Volltextzugriff (PDF)

Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients

Heart failure reviews, 2015-09, Vol.20 (5), p.573-578

2015

Volltextzugriff (PDF)

Genetic variation in the natriuretic peptide system and heart failure

Heart failure reviews, 2010-05, Vol.15 (3), p.219-228

Lanfear, David E.

2010

Volltextzugriff (PDF)

Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients

Journal of cardiovascular translational research, 2023-12, Vol.16 (6), p.1343-1348

2023

Volltextzugriff (PDF)

Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department

The American heart journal, 2008-11, Vol.156 (5), p.939-945

2008

Volltextzugriff (PDF)

Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges

Current heart failure reports, 2012-03, Vol.9 (1), p.23-32

2012

Volltextzugriff (PDF)

Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure

Cardiovascular drugs and therapy, 2019-12, Vol.33 (6), p.693-700

2019

Volltextzugriff (PDF)

PROTECTIVE RELATIONSHIP BETWEEN DPP4/GLP1 MEDICATION USE AND HEART FAILURE EVENTS IN PATIENTS WITH DIABETES

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E689-E689

2013

Volltextzugriff (PDF)

Practical Pharmacogenomic Approaches to Heart Failure Therapeutics

Current treatment options in cardiovascular medicine, 2016-10, Vol.18 (10), p.60-60, Article 60

2016

Volltextzugriff (PDF)

Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients

Journal of cardiovascular translational research, 2015-12, Vol.8 (9), p.545-553

2015

Volltextzugriff (PDF)

Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure

Cardiovascular drugs and therapy, 2013-12, Vol.27 (6), p.489-498

2013

Volltextzugriff (PDF)

Association of Genetic Variation with Gene Expression and Protein Abundance within the Natriuretic Peptide Pathway

Journal of cardiovascular translational research, 2013-10, Vol.6 (5), p.826-833

2013

Volltextzugriff (PDF)

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans

Journal of the American College of Cardiology, 2004-07, Vol.44 (1), p.165-167

2004

Volltextzugriff (PDF)

Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The HenryFord HospITalCardioPulmonary EXercise Testing (FIT-CPX) project

The American heart journal, 2016-04, Vol.174, p.167

2016

Volltextzugriff (PDF)

ACCF/AHA/HFSA 2011 Survey Results: Current Staffing Profile of Heart Failure Programs, Including Programs That Perform Heart Transplant and Mechanical Circulatory Support Device Implantation: A Report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America

Journal of the American College of Cardiology, 2011-05, Vol.57 (20), p.2115-2124

JESSUP, Mariell

2011

Volltextzugriff (PDF)

801-4 High risk genotypes for myocardial infarction are more common in African Americans than European Americans

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A267-A267

2004

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaCardiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single-Cell RNA Sequencing of the Cardiovascular System: New Looks for Old Diseases

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

Relation of Worsened Renal Function During Hospitalization for Heart Failure to Long-Term Outcomes and Rehospitalization

Ventricular Assist Devices: Is Destination Therapy a Viable Alternative in the Non-Transplant Candidate?

Adrenergic-Pathway Gene Variants Influence Beta-Blocker–Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide

Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients

Genetic variation in the natriuretic peptide system and heart failure

Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients

Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department

Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges

Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure

PROTECTIVE RELATIONSHIP BETWEEN DPP4/GLP1 MEDICATION USE AND HEART FAILURE EVENTS IN PATIENTS WITH DIABETES

Practical Pharmacogenomic Approaches to Heart Failure Therapeutics

Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients

Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure

Association of Genetic Variation with Gene Expression and Protein Abundance within the Natriuretic Peptide Pathway

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans

Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The HenryFord HospITalCardioPulmonary EXercise Testing (FIT-CPX) project

801-4 High risk genotypes for myocardial infarction are more common in African Americans than European Americans

Aktive Filter

Suchergebnisse filtern